BARDA Ventures — Equity Co-Investment
Invests in healthcare-focused countermeasure enterprises through BARDA Ventures, advancing diagnostics, vaccines, and resilient production growth stages.
BARDA Ventures is an equity co-investment program operated jointly by the Biomedical Advanced Research and Development Authority and GHIC (Global Health Investment Corporation). It applies venture capital practices — primarily equity investment rather than grants or contracts — to accelerate companies developing transformative medical countermeasures across the full health security chain. Investme…
Transformative medical countermeasure companies from seed through growth stage, spanning disease forecasting, rapid diagnostics, vaccines, therapeutics, resilient domestic manufacturing, and equitable MCM access.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Start hereNon-Dilutive Funding vs VC for Deeptech Startups
Compare non-dilutive funding and venture capital for deeptech startups, including grants, SBIR/STTR, EIC Accelerator, dilution, timing, and stage fit.
Submit & reportSAM.gov Registration and UEI Guide for Federal Grant Applicants
Learn how SAM.gov registration, UEI numbers, Grants.gov accounts, organization profiles, workspace roles, and renewal timing fit together.
BudgetIndirect Costs in Grants: Rates, MTDC, and Examples
Understand indirect costs in grants, including direct vs indirect costs, negotiated rates, de minimis rates, MTDC, funder caps, and budget narrative implications.
More from BARDA
All grants from this funder →BARDA BAA (through
🇺🇸BARDA · United States
Supports teams developing countermeasure technologies for CBRN, diagnostics, and readiness-focused therapeutics through BARDA BAA.
BARDA DRIVe ImmuneChip+ (through
🇺🇸BARDA · United States
Supports creators of immune-enabled organ-on-chip systems and biosensing manufacturing for critical health technology challenges.
Project BioShield Procurement
🇺🇸BARDA · United States
Administers late-stage medical countermeasure development with United States government procurement pathways for strategic stockpile readiness.
BARDA Accelerator Network — POC Funding
🇺🇸BARDA · United States
Funds proof-of-concept medical countermeasure projects across diagnostics, digital health, and therapeutic platforms.
BARDA Accelerator Network — Proof-of-Concept Funding
🇺🇸BARDA · United States
Supports United States health-security teams with early milestone-based funding for proof-of-concept countermeasure work.
BARDA RRPV — Member
🇺🇸BARDA · United States
Supports members of dedicated consortiums to pursue medical countermeasure proposals through BARDA rapid response partnership pathways.
Similar grants
Browse the directory →
VVP Launch Note
🇺🇸VIPC · United States
Offers Virginia startups a VVP Launch Note to convert into equity during later financing rounds.
Tesi Growth Equity Investments
🇫🇮Tesi · Finland
Invests in Finnish scaleups through Tesi with minority growth equity alongside private co investors.
Tesi Venture Capital Investments
🇫🇮Tesi · Finland
Invests in Finnish technology startups through minority equity co investment under Tesi at growth financing stages.
Virginia Invests — LP Commitment
🇺🇸VIPC · United States
Supports venture capital managers with commitments aimed at Virginia startup investment.
Myeloma Investment Fund (MIF)
MMRF · United States
Invests in early-stage multiple myeloma drug and technology companies, recycling returns into further health innovation investments.
Seed Capital Investment Program (SCIP)
🇺🇸AEDC · United States
Invests in Arkansas technology companies with flexible financing structures through debt, equity, or royalty arrangements.